Bevacizumab for Malignant Brain Gliomas. Which is the Current Evidence? [electronic resource]
Producer: 20161103Description: 136-43 p. digitalISSN:- 1872-213X
- Angiogenesis Inhibitors -- therapeutic use
- Bevacizumab -- therapeutic use
- Brain Neoplasms -- drug therapy
- Clinical Trials as Topic
- Drug and Narcotic Control
- Evidence-Based Medicine
- Glioma -- drug therapy
- Humans
- Molecular Targeted Therapy
- Patents as Topic
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.